BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

952 related articles for article (PubMed ID: 21861858)

  • 1. Mesenchymal stem cell effects on T-cell effector pathways.
    Duffy MM; Ritter T; Ceredig R; Griffin MD
    Stem Cell Res Ther; 2011 Aug; 2(4):34. PubMed ID: 21861858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases.
    Li CL; Leng Y; Zhao B; Gao C; Du FF; Jin N; Lian QZ; Xu SY; Yan GL; Xia JJ; Zhuang GH; Fu QL; Qi ZQ
    Stem Cells; 2017 Jul; 35(7):1719-1732. PubMed ID: 28520232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effects of mesenchymal stromal cells-derived exosome.
    Chen W; Huang Y; Han J; Yu L; Li Y; Lu Z; Li H; Liu Z; Shi C; Duan F; Xiao Y
    Immunol Res; 2016 Aug; 64(4):831-40. PubMed ID: 27115513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.
    Selmani Z; Naji A; Zidi I; Favier B; Gaiffe E; Obert L; Borg C; Saas P; Tiberghien P; Rouas-Freiss N; Carosella ED; Deschaseaux F
    Stem Cells; 2008 Jan; 26(1):212-22. PubMed ID: 17932417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
    Carrión F; Nova E; Luz P; Apablaza F; Figueroa F
    Immunol Lett; 2011 Mar; 135(1-2):10-6. PubMed ID: 20888363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory Ecto-Mesenchymal Stem Cell-Derived Exosomes Ameliorate Experimental Colitis
    Tian J; Zhu Q; Zhang Y; Bian Q; Hong Y; Shen Z; Xu H; Rui K; Yin K; Wang S
    Front Immunol; 2020; 11():598322. PubMed ID: 33362781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway.
    Chen D; Tang P; Liu L; Wang F; Xing H; Sun L; Jiang Z
    Cell Cycle; 2018; 17(7):858-867. PubMed ID: 29493401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets.
    Özdemir AT; Özgül Özdemir RB; Kırmaz C; Sarıboyacı AE; Ünal Halbutoğlları ZS; Özel C; Karaöz E
    Cell Immunol; 2016 Dec; 310():108-115. PubMed ID: 27576175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The investigation of immunomodulatory effects of adipose tissue mesenchymal stem cell educated macrophages on the CD4 T cells.
    Özdemir RBÖ; Özdemir AT; Sarıboyacı AE; Uysal O; Tuğlu Mİ; Kırmaz C
    Immunobiology; 2019 Jul; 224(4):585-594. PubMed ID: 31072631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dental follicle mesenchymal stem cells down-regulate Th2-mediated immune response in asthmatic patients mononuclear cells.
    Genç D; Zibandeh N; Nain E; Gökalp M; Özen AO; Göker MK; Akkoç T
    Clin Exp Allergy; 2018 Jun; 48(6):663-678. PubMed ID: 29498435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences of Clonogenic Mesenchymal Stem Cells on Immunomodulation of Lymphocyte Subsets.
    Martínez-Peinado P; Pascual-García S; Roche E; Sempere-Ortells JM
    J Immunol Res; 2018; 2018():7232717. PubMed ID: 30271793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity.
    Reading JL; Yang JH; Sabbah S; Skowera A; Knight RR; Pinxteren J; Vaes B; Allsopp T; Ting AE; Busch S; Raber A; Deans R; Tree TI
    J Immunol; 2013 May; 190(9):4542-52. PubMed ID: 23547116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
    Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
    Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions.
    Bassani B; Tripodo C; Portararo P; Gulino A; Botti L; Chiodoni C; Jachetti E; Bolli N; Ciciarello M; Joehrens K; Anagnostopoulos I; Na IK; Curti A; Colombo MP; Sangaletti S
    Front Immunol; 2021; 12():662048. PubMed ID: 34084166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 Cells.
    Wang LT; Jiang SS; Ting CH; Hsu PJ; Chang CC; Sytwu HK; Liu KJ; Yen BL
    Stem Cells; 2018 Jun; 36(6):903-914. PubMed ID: 29396902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity.
    Zhang X; Ren X; Li G; Jiao C; Zhang L; Zhao S; Wang J; Han ZC; Li X
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3143-52. PubMed ID: 21296818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine peripheral non-conventional TCRαβ
    Protschka M; Di Placido D; Moore PF; Büttner M; Alber G; Eschke M
    Front Immunol; 2024; 15():1400550. PubMed ID: 38835756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
    Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
    J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets.
    Pianta S; Bonassi Signoroni P; Muradore I; Rodrigues MF; Rossi D; Silini A; Parolini O
    Stem Cell Rev Rep; 2015 Jun; 11(3):394-407. PubMed ID: 25348066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.